This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Patient Safety Technologies Completes $6.0 Million Equity Financing

NEWTOWN, Pa., June 25 /PRNewswire-FirstCall/ -- Patient Safety Technologies, Inc. (OTC Bulletin Board: PSTX) (the "Company") announced today the closing of a $6.0 million private placement financing.  The new capital will primarily be used to fund working capital and the continued growth of the Company.

Additionally, Brian E. Stewart has been appointed as President, Chief Executive Officer and Board Member of the Company.  Mr. Stewart is the co-founder of SurgiCount Medical, the Company's primary operating subsidiary, and co-inventor of the Safety-Sponge® System.  Additionally, Mr. Stewart brings over 15 years of experience financing and advising both public and private companies in addition to his experience as VP Business Development of SurgiCount Medical.  "I look forward to leading the Company at this exciting time.  With an ever increasing customer base validating the effectiveness of the Safety-Sponge® System, top-tier supply chain partners and a strengthened balance sheet, I believe we are well positioned to become the standard of care for addressing one of the most common errors in surgery, retained surgical sponges," said Mr. Stewart.

Prior to the appointment of Mr. Stewart as CEO and Director, Messrs. Chase, McFarland, Bauer and Hitchcock resigned as Directors and Steven Kane resigned as a Director, President and Chief Executive Officer.  The Board of Directors now consists of Brian Stewart, Wayne Lin, John Francis, Louis Glazer and Herbert Langsam.

In connection with the financing, certain of the stockholders who previously called for a special meeting of stockholders requesting the removal of certain directors have withdrawn such demand.  As a result, under the Company's by-laws, the demand is no longer in effect.

Additional details on the transaction will be provided in an upcoming Form 8-K filing with the Securities and Exchange Commission.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
PSTX $0.00 0.00%
AAPL $126.70 0.23%
FB $80.01 -1.50%
GOOG $567.61 -1.30%
TSLA $194.26 -3.20%

Markets

DOW 17,856.78 -278.94 -1.54%
S&P 500 2,071.26 -29.78 -1.42%
NASDAQ 4,927.37 -55.4390 -1.11%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs